- Home
- PT vs EDSA Comparison
PT vs EDSA Comparison
Compare PT & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PT
- EDSA
- Stock Information
- Founded
- PT 2012
- EDSA 2015
- Country
- PT China
- EDSA Canada
- Employees
- PT N/A
- EDSA N/A
- Industry
- PT Computer Software: Programming Data Processing
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- PT Technology
- EDSA Health Care
- Exchange
- PT Nasdaq
- EDSA Nasdaq
- Market Cap
- PT 14.8M
- EDSA 6.1M
- IPO Year
- PT 2018
- EDSA N/A
- Fundamental
- Price
- PT $0.94
- EDSA $1.73
- Analyst Decision
- PT
- EDSA Strong Buy
- Analyst Count
- PT 0
- EDSA 1
- Target Price
- PT N/A
- EDSA $21.00
- AVG Volume (30 Days)
- PT 26.5K
- EDSA 30.6K
- Earning Date
- PT 12-30-2024
- EDSA 02-07-2025
- Dividend Yield
- PT N/A
- EDSA N/A
- EPS Growth
- PT N/A
- EDSA N/A
- EPS
- PT N/A
- EDSA N/A
- Revenue
- PT $4,479,352.00
- EDSA N/A
- Revenue This Year
- PT N/A
- EDSA N/A
- Revenue Next Year
- PT N/A
- EDSA N/A
- P/E Ratio
- PT N/A
- EDSA N/A
- Revenue Growth
- PT N/A
- EDSA N/A
- 52 Week Low
- PT $0.71
- EDSA $1.55
- 52 Week High
- PT $1.27
- EDSA $5.99
- Technical
- Relative Strength Index (RSI)
- PT 49.80
- EDSA 31.51
- Support Level
- PT $0.90
- EDSA $1.73
- Resistance Level
- PT $0.98
- EDSA $1.99
- Average True Range (ATR)
- PT 0.07
- EDSA 0.19
- MACD
- PT -0.00
- EDSA 0.02
- Stochastic Oscillator
- PT 44.44
- EDSA 18.00
About PT Pintec Technology Holdings Limited
Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.